RUNX3/H3K27me3 co-expression defined some specific pTNM-I NSCLC population with higher proportion of apoptotic index and thus better prognosis and longer OS and could probably be used as a biomarker in the prediction of postoperative relapse and metastasis. This evidence concerns the gene RUNX3 and non-small cell lung carcinoma.